Precision mouse models of Yars/dominant intermediate Charcot-Marie-Tooth disease type C and Sptlc1/hereditary sensory and autonomic neuropathy type 1

被引:11
|
作者
Hines, Timothy J. [1 ]
Tadenev, Abigail L. D. [1 ]
Lone, Museer A. [2 ]
Hatton, Courtney L. [1 ]
Bagasrawala, Inseyah [1 ]
Stum, Morgane G. [1 ]
Miers, Kathy E. [1 ]
Hornemann, Thorsten [2 ]
Burgess, Robert W. [1 ]
机构
[1] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA
[2] Univ Zurich, Inst Clin Chem, Zurich, Switzerland
基金
瑞士国家科学基金会; 美国国家卫生研究院;
关键词
axon degeneration; Charcot-Marie-Tooth; demyelination; HSN1; inherited peripheral neuropathy; sphingolipid synthesis; SPTLC2; tRNA synthetase; YARS; TRANSFER-RNA SYNTHETASE; SERINE PALMITOYLTRANSFERASE; MUTATIONS; SUBUNIT; SPTLC1; ACCUMULATION; TRANSFERASE; EXPRESSION; PHENOTYPE; CELLS;
D O I
10.1111/joa.13605
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Animal models of neurodegenerative diseases such as inherited peripheral neuropathies sometimes accurately recreate the pathophysiology of the human disease, and sometimes accurately recreate the genetic perturbations found in patients. Ideally, models achieve both, but this is not always possible; nonetheless, such models are informative. Here we describe two animal models of inherited peripheral neuropathy: mice with a mutation in tyrosyl tRNA-synthetase, Yars(E196K), modeling dominant intermediate Charcot-Marie-Tooth disease type C (diCMTC), and mice with a mutation in serine palmitoyltransferase long chain 1, Sptlc1(C133W), modeling hereditary sensory and autonomic neuropathy type 1 (HSAN1). Yars(E196K) mice develop disease-relevant phenotypes including reduced motor performance and reduced nerve conduction velocities by 4 months of age. Peripheral motor axons are reduced in size, but there is no reduction in axon number and plasma neurofilament light chain levels are not increased. Unlike the dominant human mutations, the Yars(E196K) mice only show these phenotypes as homozygotes, or as compound heterozygotes with a null allele, and no phenotype is observed in E196K or null heterozygotes. The Sptlc1(C133W) mice carry a knockin allele and show the anticipated increase in 1-deoxysphingolipids in circulation and in a variety of tissues. They also have mild behavioral defects consistent with HSAN1, but do not show neurophysiological defects or axon loss in peripheral nerves or in the epidermis of the hind paw or tail. Thus, despite the biochemical phenotype, the Sptlc1(C133W) mice do not show a strong neuropathy phenotype. Surprisingly, these mice were lethal as homozygotes, but the heterozygous genotype studied corresponds to the dominant genetics seen in humans. Thus, Yars(E196K) homozygous mice have a relevant phenotype, but imprecisely reproduce the human genetics, whereas the Sptlc1(C133W) mice precisely reproduce the human genetics, but do not recreate the disease phenotype. Despite these shortcomings, both models are informative and will be useful for future research.
引用
收藏
页码:1169 / 1185
页数:17
相关论文
共 50 条
  • [21] KINSHIP WITH AUTOSOMAL HEREDITARY MOTOR AND SENSORY NEUROPATHY (CHARCOT-MARIE-TOOTH DISEASE)
    VANWEERDEN, TW
    HOUTHOFF, HJ
    SEELEN, W
    MINDERHOUD, JM
    CLINICAL NEUROLOGY AND NEUROSURGERY, 1976, 79 (04) : 329 - 329
  • [22] AUDITORY FUNCTION IN HEREDITARY MOTOR AND SENSORY NEUROPATHY (CHARCOT-MARIE-TOOTH DISEASE)
    RAGLAN, E
    PRASHER, DK
    TRINDER, E
    RUDGE, P
    ACTA OTO-LARYNGOLOGICA, 1987, 103 (1-2) : 50 - 55
  • [23] Characterization of Two Mutations in the SPTLC1 Subunit of Serine Palmitoyltransferase Associated with Hereditary Sensory and Autonomic Neuropathy Type I
    Rotthier, Annelies
    Penno, Anke
    Rautenstrauss, Bernd
    Auer-Grumbach, Michaela
    Stettner, Georg M.
    Asselbergh, Bob
    Van Hoof, Kim
    Sticht, Heinrich
    Levy, Nicolas
    Timmerman, Vincent
    Hornemann, Thorsten
    Janssens, Katrien
    HUMAN MUTATION, 2011, 32 (06) : E2211 - E2225
  • [24] Charcot-Marie-Tooth neuropathy type 1 associated with familial hypodontia
    Severin, E
    Ioachim, I
    JOURNAL OF MEDICAL GENETICS, 2002, 39 : S46 - S46
  • [25] LINKAGE STUDIES ON CHARCOT-MARIE-TOOTH NEUROPATHY TYPE-1
    GRIFFITHS, LR
    ZWI, MB
    MCLEOD, JG
    NICHOLSON, GA
    CYTOGENETICS AND CELL GENETICS, 1987, 46 (1-4): : 624 - 624
  • [26] Utility of Charcot-Marie-Tooth Neuropathy Score in Children With Type 1A Disease
    Haberlova, Jana
    Seeman, Pavel
    PEDIATRIC NEUROLOGY, 2010, 43 (06) : 407 - 410
  • [27] Dominant intermediate Charcot-Marie-Tooth type C: A new heterozygous missense mutation
    Ricci, G.
    Piazza, S.
    Angiari, C.
    Fabrizi, G. M.
    Siciliano, G.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2007, 12 (02) : 169 - 169
  • [28] Reversible inflammatory neuropathy superimposed on Charcot-Marie-Tooth type 1A disease
    José Gazulla
    Carmen Almárcegui
    José Berciano
    Neurological Sciences, 2018, 39 : 793 - 794
  • [29] Reversible inflammatory neuropathy superimposed on Charcot-Marie-Tooth type 1A disease
    Gazulla, Jose
    Almarcegui, Carmen
    Berciano, Jose
    NEUROLOGICAL SCIENCES, 2018, 39 (04) : 793 - 794
  • [30] Different SPTLC1 mutations in hereditary sensory neuropathy type 1 are associated with distinct clinical phenotypes
    Spring, P. J.
    Spies, J. M.
    Dawkins, J. L.
    Hulme, D.
    Blair, I. P.
    Kennerson, M.
    Nicholson, G. A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2007, 12 : 84 - 84